Hong Joung Boom, Choi Cheol Woong, Kim Hyung Wook, Kang Dae Hwan, Park Su Bum, Kim Su Jin, Kim Dong Jun
Joung Boom Hong, Cheol Woong Choi, Hyung Wook Kim, Dae Hwan Kang, Su Bum Park, Su Jin Kim, Dong Jun Kim, Department of Internal Medicine, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Gyeongsangnam-do 626-770, South Korea.
World J Gastroenterol. 2015 Mar 14;21(10):2982-7. doi: 10.3748/wjg.v21.i10.2982.
To evaluate the safety and feasibility of endoscopic resection using band ligation (EMR-B) for the diagnostic and therapeutic removal of tumors located in the esophageal subepithelial region having originated from the submucosa.
From May 2009 to September 2014, after medical chart and endoscopic ultrasonography report review, a total of 15 esophageal tumors located in the submucosal layer were resected by EMR-B. Previous symptom, location, pathology, complete resection rate, incidence of complications, incidence of minor complication, size, length of procedures time and follow up months were evaluated. To evaluate local recurrence at the resection site, periodic follow-up endoscopic examination was undertaken in all of the patients. The first endoscopic examination was performed about 6 mo after the endoscopic resection. Thereafter, the endoscopic follow up were scheduled annually.
The mean age was 50.3 ± 9.67 years. The mean tumor size was 6.93 ± 3.15 mm and most of the lesions size was between 5-10 mm in diameter (10/15, 66.6%). In all patients, endoscopic en bloc resection was achieved. In one patient, the vertical margin was involved. The mean procedural time was 8.86 ± 3.66 min. In all patients, no evidence of severe complications such as perforation or bleeding occurred. Minor complications such as chest pain (2/15, 13.3%) and heartburn (3/15, 13.3%) were reported but they symptoms were controlled by proton pump inhibitors, ulcermin and/or analgesics. Histologic assessments of the removed specimens revealed 10 granular cell tumors (66.6%), 4 leiomyomas (16.6%) and one lipoma (6.6%). No recurrence was observed during the mean follow up period of 45 ± 3.5 mo (range: 5-64 mo).
EMR-B might be considered safe and effective for the diagnosis and treatment of lesions measuring less than 10 mm in diameter.
评估使用套扎术的内镜下切除术(EMR - B)对起源于黏膜下层的食管上皮下区域肿瘤进行诊断性和治疗性切除的安全性和可行性。
2009年5月至2014年9月,在查阅病历和内镜超声报告后,共对15例位于黏膜下层的食管肿瘤行EMR - B切除术。评估既往症状、位置、病理、完整切除率、并发症发生率、轻微并发症发生率、大小、手术时间及随访月数。为评估切除部位的局部复发情况,对所有患者进行定期随访内镜检查。首次内镜检查在内镜切除术后约6个月进行。此后,内镜随访安排为每年一次。
平均年龄为50.3±9.67岁。平均肿瘤大小为6.93±3.15mm,大多数病变直径在5 - 10mm之间(10/15,66.6%)。所有患者均实现内镜下整块切除。1例患者切缘垂直方向受累。平均手术时间为8.86±3.66分钟。所有患者均未出现穿孔或出血等严重并发症。报告了轻微并发症,如胸痛(2/15,13.3%)和烧心(3/15,13.3%),但这些症状通过质子泵抑制剂、胃黏膜保护剂和/或镇痛药得到控制。切除标本的组织学评估显示10例颗粒细胞瘤(66.6%)、4例平滑肌瘤(16.6%)和1例脂肪瘤(6.6%)。在平均45±3.5个月(范围:5 - 64个月)的随访期内未观察到复发。
EMR - B对于直径小于10mm的病变的诊断和治疗可能是安全有效的。